Epirium Bio Announces First Participants Dosed in Phase 1 Clinical Trial in Healthy Volunteers, Evaluating MF-300, a First-In-Class, Oral 15-PGDH Enzyme Inhibitor, for the Treatment of Sarcopenia by Seini Moimoi | Jan 30, 2025 | Portfolio News
Cohere Health Unveils Cohere Connect™ to Address Prior Authorization Compliance Gaps for Health Plans by Seini Moimoi | Jan 29, 2025 | Portfolio News
Cohere Health Achieves Significant Growth in 2024, Accelerating Momentum as the Leader in AI-Driven Clinical Intelligence by Seini Moimoi | Jan 14, 2025 | Portfolio News
Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor by Seini Moimoi | Jan 13, 2025 | Portfolio News
Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates by Seini Moimoi | Jan 10, 2025 | Portfolio News
Alentis Announces Positive Topline Results from Two Studies of Lixudebart (ALE.F02) in Patients with ANCA-RPGN and Advanced Liver Fibrosis by Seini Moimoi | Jan 9, 2025 | Portfolio News
